# Silence Therapeutics plc: Form 8-K, filed Aug 12, 2026

- Company: [Silence Therapeutics plc](/companies/sln.md) (CIK 1479615)
- Form: 8-K
- Filed: 2026-08-12
- Accepted by EDGAR: Aug 12, 2026, 17:23 ET
- Period: 2026-08-10
- Accession: 0001193125-26-347196
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/d168365d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/d168365d8k.htm

Filed Aug 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-347196. Last ingested by Listed: Nov 5, 2026, 14:00 ET. No prices; not investment advice.